Galderma to Acquire ZO Skin Health for $1.5 Billion
The Swiss dermatology company will purchase ZO Skin Health from its current shareholders to expand its portfolio.
Business & Markets • 2 hours ago
Galderma, a Swiss dermatology company, has announced an agreement to acquire ZO Skin Health for $1.5 billion. The acquisition will be made from current shareholders, including the Obagi family and funds managed by Blackstone Tactical Opportunities.
ZO Skin Health, founded by dermatologist Dr. Zein Obagi, offers a range of skincare products. This move by Galderma is aimed at strengthening its position in the premium skincare market and expanding its product offerings.
The transaction is expected to be finalized in the first half of 2024, subject to customary closing conditions. Galderma has stated that the acquisition aligns with its strategy to grow its consumer care business and broaden its portfolio of science-based skincare solutions.